Yes, the Japan DMAH (Designated Marketing Authorization Holder) can facilitate regulatory pathway consultation with the PMDA (Pharmaceuticals and Medical Devices Agency). They act as a liaison, helping foreign companies navigate Japan’s regulatory requirements, ensuring compliance, and streamlining communication with the PMDA for efficient product approval processes.
